ロード中...
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations
BACKGROUND: New hepatitis C virus (HCV) therapies have improved efficacy, allowed pangenotypic applications, increased barriers to drug resistance and shortened therapy duration. METHODS: Patients infected with different HCV genotypes were divided into two groups: group 1 included 169 patients recei...
保存先:
| 出版年: | Infect Drug Resist |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6627173/ https://ncbi.nlm.nih.gov/pubmed/31372005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S205282 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|